A Clinical Study of ANX005 and IVIG in Subjects With Guillain Barré Syndrome (GBS)
Clinical trial NCT04035135 · COMPLETED
Trial details
- NCT number
- NCT04035135
- Sponsor
- Annexon, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-01-29
- Primary completion
- 2021-05-19
- Enrollment
- 14
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.